Presenter: G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
In episode 485, Mike and James go over a couple of COVID trials that show two different anti-inflammatories – colchicine and inhaled budesonide – seem to have an effect on reducing hospitalizations or urgent care visits. 1) Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial Lancet…
In the Clinic Episode #21: Low Back Pain
In the Clinic Episode #20: Bronchiolitis
In the Clinic Episode #19: Alcohol use disorder
![](https://cfpclearn.ca/wp-content/uploads/2022/09/CroppedIllustrations-30.png)
Presenter(s):
G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
Please provide any additional comments (optional).